Evolent Health's GAAP loss for 9 months of 2020 was $320.443 million, up 3 times from $106.287 million in the previous year. Revenue increased 23.1% to $750.51 million, against $609.858 million a year earlier.
Evolent Health's GAAP loss for 9 months of 2020 was $320.443 million, up 3 times from $106.287 million in the previous year. Revenue increased 23.1% to $750.51 million, against $609.858 million a year earlier. 
ir.evolenthealth.com
English (US) 